Downstate Researchers Target Multiple Sclerosis

Main Category: Multiple Sclerosis
Also Included In: Neurology / Neuroscience
Article Date: 25 Nov 2006 - 21:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  


Current Article Ratings:

Patient / Public:5 stars

4.6 (25 votes)

Healthcare Prof:5 stars

4.86 (7 votes)


Researchers at SUNY Downstate Medical Center have developed a substance that inhibits the progress of multiple sclerosis (MS) in an animal model. The agent, a novel calpain inhibitor, can be administered orally.

Calpains are a family of proteolytic enzymes naturally found in the human body. Inappropriate activation of calpain is associated with a number of neurodegenerative and autoimmune diseases such as MS. It is known to destroy the myelin sheath that coats and protects the nerves.

In a paper published in the Journal of Neuroimmunology, SUNY Downstate and Maimonides Medical Center researchers described the use of the calpain inhibitor for the treatment of a mouse model of MS. Whether administered by injection or by mouth, the inhibitor produced an almost complete cessation of the disease's progress.

The calpain inhibitor, developed at Downstate, was shown to reduce clinical illness signs and prevent demyelination and inflammatory infiltration in a dose- and time-dependant manner, and holds promise in treating both the acute and chronic phases of MS. The inhibitor may also prove beneficial for treating other degenerative illnesses, such as Alzheimer's, Huntington's and Parkinson's disease.

###

The research was conducted by Getaw Hassen, MD, PhD, as his doctoral thesis in SUNY Downstate's School of Graduate Studies. Faroozan Mokhtarian, PhD, MPH, associate professor of medicine and of microbiology and immunology at Downstate, developed the mouse model. The inhibitor was developed by Leo Kesner, PhD, professor emeritus of biochemistry, and Alfred Stracher, PhD, distinguished professor of biochemistry.

SUNY Downstate Medical Center comprises a College of Medicine, Colleges of Nursing and Health Related Professions, a School of Graduate Studies, and University Hospital of Brooklyn.

Contact: Ron Najman
SUNY Downstate Medical Center

Article adapted by Medical News Today from original press release.
Visit our multiple sclerosis section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Ron Najman. "Downstate Researchers Target Multiple Sclerosis." Medical News Today. MediLexicon, Intl., 25 Nov. 2006. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/57333.php>

APA
Ron Najman. (2006, November 25). "Downstate Researchers Target Multiple Sclerosis." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/57333.php.

Please note: If no author information is provided, the source is cited instead.




Multiple Sclerosis

Most Popular Articles



Follow Our Multiple Sclerosis News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Multiple Sclerosis Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »